Join
Live feed
·
NEWSReleasevia Quantisnow
VBI Vaccines Inc. New logo

VBI Vaccines To Present New Interim Phase 2b Data From VBI-1901 In Recurrent Glioblastoma Patients In Poster Presentation At 2024 ASCO Annual Meeting

ByQuantisnow·Wall Street's wire, on your screen.
VBIV· VBI Vaccines Inc. New
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VBIV (VBI Vaccines Inc. New) and more on Quantisnow.